Nurix TherapeuticsNRIX

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Dr. Arthur T. Sands, M.D.,PhD

$693M

Market Cap • 17/04/2024

2009

(há 15 anos)
Fundação

2020

(4 years ago)
IPO

NASDAQ

Listagem
Flag of US

San Francisco

Sede • California

297

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

NRIXSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-9%

1 dia

15/04/2024

-10%

1 semana

10/04/2024

10%

1 mês

18/03/2024

6%

1 ano

17/04/2023

10 anos

Histórico